Latest Renewables News

Enero Group reports improved profitability in FY25 despite revenue decline, driven by divestment and AI innovation, with FY26 Q1 EBITDA up 13%.

Treasury Wine Estates reported robust fiscal 2025 results driven by luxury wine growth and acquisitions, yet has downgraded its fiscal 2026 earnings outlook due to weakening demand in China and distribution disruptions in California.

Alkane Resources reports its inaugural JORC-compliant Mineral Resources and Ore Reserves for the Costerfield Property, highlighting a robust resource base and a mine life extended to 2030. The recent True Blue Deposit discovery further bolsters the project’s potential.

Pinnacle Minerals Limited has had its trading suspension lifted following a significant announcement about an acquisition and capital raise, signaling renewed momentum for the mining explorer.

Catalina Resources unveils a revitalised strategy targeting gold, rare earths, and lithium across Western Australia’s underexplored regions, backed by strong leadership and a solid cash position.

Vital Metals has locked in firm commitments for an extra $5.6 million placement, building on its August raise, to accelerate development of its Tardiff rare earths deposit in Canada.

Compumedics has secured a $2.15 million placement to fast-track commercialisation of its Somfit D device following early FDA approval, positioning the company for significant growth in the US home sleep testing market.

Origin Energy reported a robust FY25 with a $1.48 billion profit and increased dividends, while reaffirming its commitment to net zero emissions by 2050 through its updated Climate Transition Action Plan.

St George Mining’s latest drilling results reveal a thick, high-grade rare earth and niobium mineralisation extending well beyond the existing resource at its Araxá project in Brazil, hinting at a major resource upgrade.

Ryder Capital Limited celebrated its 10th year on the ASX with robust FY25 results, including a 27.5% pre-tax NTA growth and a new quarterly dividend policy increasing payouts by 20%. The company also renewed its investment management agreement for five years.

Articore Group Limited has reported its first profitable quarter in four years, delivering a $0.8 million EBIT in 1QFY26 and reaffirming its FY26 guidance amid strategic investments in AI and new product launches.

Proteomics International has expanded its partnership with the University of Melbourne and Royal Women’s Hospital to further validate and develop its PromarkerEndo blood test, aiming to revolutionize endometriosis diagnosis.